North America Ventricular Assist Device Market: Overview
Advance Heart Failure is characterized as
weakening of the heart caused due to failure of the left ventricle, due
to which the heart is unable to pump blood to different parts of the
body. According to the AHA (American Heart Association), 5.7 Mn people
in the U.S suffer from heart failure and 300,000 die each year of heart
failure. Moreover, the AHA predicts that advance heart failure will
become the most common cause of death globally. However, these
statistics have already materialized in the U.S. and Canada, where
advance heart failure is currently said to be the leading cause of
mortality. In Canada, the figures are rising day by day. In Canada
nearly 600,000 of the total is affected by heart failure. A large
proportion of these population can be saved with proper treatment and
care. Thus, the existence of an unmet medical need is clearly evident
and is anticipated to augment the ventricular assist device market.
Report Overview @ https://www.transparencymarketresearch.com/north-america-ventricular-assist-device-market.html
North America Ventricular Assist Device Market: Scope of the Study
This report on the ventricular assist
device market in the North America analyzes the current and future
prospects of the market. The report comprises an elaborate executive
summary, including a market snapshot that provides overall information
of various segments and sub-segments. The research is a combination of
primary and secondary research. Detailed qualitative analysis of factors
responsible for driving and restraining market growth and opportunities
has been provided in the market overview section. Market revenue in
terms of US$ Mn for the period between 2014 and 2024 along with the
compound annual growth rate (CAGR %) from 2014 to 2024 are provided for
all the segments, considering 2015 as the base year. Market related
factors such as technological developments, patent expiry, recent
approvals, investment in clinical studies and acquisitions by leading
players in the market, and historical year-on-year growth have been
taken into consideration while estimating the market size. Growth rates
for each segment within the North America ventricular assist device
market have been determined after a thorough analysis of past trends,
demographics, future trends, technological developments, drug
development life cycle, and regulatory requirements. These factors would
help the market players to take strategic decisions in order to
strengthen their positions and expand their share in the ventricular
assist device market in North America.
Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16508
North America Ventricular Assist Device Market: Segmentation
Based on product type, the North America
ventricular assist device market has been segmented into Left
Ventricular Assist Device (LVAD), Right Ventricular Assist Device
(RVAD), Biventricular Assist Device (Bi-VAD) and total artificial heart
(TAH).
Based on indication, the North America
ventricular assist device market has been segmented into bridge to
transplant (BTT), destination therapy (DT) and bridge to recovery (BTR).
The American Heart Association reported that 2.6% of the total
population is suffering from cardiovascular disease and heart failure is
the leading cause of death in the U.S. and around 1.6% in Canada suffer
from heart failure, and the number is rising each year. Therefore
consequently driving the ventricular assist device market in North
America during the forecast period.
North America Ventricular Assist Device Market: Geographical Outlook
Geographically, the North America
ventricular assist device market has been segmented into two countries:
the U.S. and Canada. These countries have been further segmented by
indication and product type. The competition matrix section included in
the report is likely to assist the existing players to increase their
market shares and new companies to establish their presence in the
ventricular assist device market in North America.
Companies Mentioned in the Report
The report also profiles major players in
the market based on various attributes such as company overview,
financial overview, SWOT analysis, key business strategies, product
portfolio, and recent developments. Key companies profiled in the report
include ABIOMED, St. Jude Medical, HeartWare, SynCardia Systems LLC,
Sunshine Heart, Inc., Berlin Heart GmbH
No comments:
Post a Comment